⁍ AstraZeneca’s U.S. trial was paused on Sept. 6 after a report of a serious neurological illness.
⁍ An oversight panel has recommended that Johnson & Johnson resume its trial as well.
– Johnson & Johnson and AstraZeneca resumed clinical trials of their experimental vaccines today after the FDA cleared them, Reuters reports. The trials were halted last week after a study participant was found to have a rare form ofmyelitis, which is believed to be the cause of the illness that halted AstraZeneca’s US trial. An FDA oversight panel recommended that Johnson & Johnson resume its trial as well.
Source: https://www.reuters.com/article/health-coronavirus-astrazeneca-usa-int/astrazeneca-resumes-us-covid-19-vaccine-trial-optimism-seen-for-jj-idUSKBN2782L1